Kovalski, Joanna R. https://orcid.org/0000-0001-8436-6656
Sarioglu, Goksu https://orcid.org/0000-0002-2864-5682
Subramanyam, Vishvak
Hernandez, Grace
Rademaker, Gilles
Oses-Prieto, Juan A. https://orcid.org/0000-0003-4759-2341
Slota, Macey https://orcid.org/0000-0002-6461-4736
Mohan, Nimmy
Yiakis, Kaylee
Liu, Isabelle https://orcid.org/0009-0009-7871-2722
Wen, Kwun Wah
Kim, Grace E. https://orcid.org/0000-0003-4603-9448
Miglani, Sohit https://orcid.org/0000-0002-8075-320X
Burlingame, Alma L.
Goodarzi, Hani https://orcid.org/0000-0002-9648-8949
Perera, Rushika M. https://orcid.org/0000-0003-2435-2273
Ruggero, Davide https://orcid.org/0000-0002-9444-5865
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA242986, R01CA240603)
American Cancer Society (American Cancer Society Research Professor Award, 133966‐PF‐20‐009‐01‐RMC)
AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grant; Ed Marra Passion to Win Fund
Article History
Received: 29 April 2024
Accepted: 20 December 2024
First Online: 4 February 2025
Competing interests
: D.R. is a shareholder of eFFECTOR Therapeutics, Inc. and is a member of its scientific advisory board. The other authors declare no competing interests.